FdaApplication
ANDA 085046
Identifiers
- fda_app_no: ANDA085046
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
1 product